Holen Sie sich die Stockscreener-App
23.49
0.63%
-0.15
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BAX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$23.64
Offen:
$23.84
24-Stunden-Volumen:
4.80M
Relative Volume:
0.74
Marktkapitalisierung:
$12.14B
Einnahmen:
$11.32B
Nettoeinkommen (Verlust:
$-981.00M
KGV:
-12.03
EPS:
-1.9532
Netto-Cashflow:
$714.00M
1W Leistung:
+0.51%
1M Leistung:
-8.60%
6M Leistung:
+40.83%
1J Leistung:
+1.12%
1-Tages-Spanne:
$23.40
$23.85
1-Wochen-Bereich:
$23.11
$24.09
52-Wochen-Spanne:
$15.73
$30.00
Baxter International Inc Stock (BAX) Company Profile
Firmenname
Baxter International Inc
Sektor
Telefon
(224) 948-2000
Adresse
ONE BAXTER PARKWAY, DEERFIELD, IL
Compare BAX vs ISRG, BDX, RMD, MDLN, ALC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
23.49 | 12.08B | 11.32B | -981.00M | 714.00M | -1.9532 |
ISRG
Intuitive Surgical Inc
|
391.95 | 143.14B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
176.80 | 50.07B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
218.89 | 32.02B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
35.61 | 30.44B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
63.76 | 31.16B | 10.63B | 819.00M | 1.59B | 1.6577 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-31 | Herabstufung | Argus | Buy → Hold |
| 2025-08-04 | Herabstufung | Stifel | Buy → Hold |
| 2025-08-01 | Herabstufung | Goldman | Buy → Neutral |
| 2025-02-26 | Fortgesetzt | Goldman | Buy |
| 2025-02-24 | Hochstufung | Argus | Hold → Buy |
| 2025-02-20 | Fortgesetzt | Barclays | Overweight |
| 2024-07-15 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2024-05-30 | Eingeleitet | Goldman | Neutral |
| 2024-05-10 | Herabstufung | TD Cowen | Buy → Hold |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-01-06 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-05 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-01-03 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-12-19 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-12-15 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-12-12 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-06-24 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | Herabstufung | Goldman | Neutral → Sell |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-02-18 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2022-02-18 | Bestätigt | Morgan Stanley | Overweight |
| 2022-02-18 | Bestätigt | Raymond James | Outperform |
| 2022-02-18 | Bestätigt | Stifel | Buy |
| 2022-02-18 | Bestätigt | UBS | Neutral |
| 2022-02-18 | Bestätigt | Wells Fargo | Overweight |
| 2022-02-11 | Eingeleitet | Goldman | Neutral |
| 2022-01-07 | Fortgesetzt | Citigroup | Buy |
| 2022-01-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-09-13 | Hochstufung | Cowen | Market Perform → Outperform |
| 2021-09-03 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-05-25 | Eingeleitet | Barclays | Equal Weight |
| 2021-01-29 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-01-06 | Herabstufung | UBS | Buy → Neutral |
| 2020-12-15 | Herabstufung | Goldman | Buy → Neutral |
| 2020-10-01 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-09-04 | Herabstufung | Argus | Buy → Hold |
| 2020-06-24 | Eingeleitet | Oppenheimer | Outperform |
| 2020-03-19 | Hochstufung | Stifel | Hold → Buy |
| 2020-03-18 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-05 | Eingeleitet | Citigroup | Neutral |
| 2020-02-13 | Eingeleitet | Goldman | Buy |
| 2020-01-02 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2019-12-17 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2019-04-08 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-01-02 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-01-02 | Hochstufung | Morgan Stanley | Underweight → Overweight |
| 2018-11-02 | Hochstufung | Argus | Hold → Buy |
| 2018-10-16 | Eingeleitet | Barclays | Underweight |
| 2018-05-17 | Fortgesetzt | Piper Jaffray | Overweight |
| 2018-02-06 | Bestätigt | Citigroup | Neutral |
| 2018-01-03 | Eingeleitet | Evercore ISI | Outperform |
| 2018-01-03 | Hochstufung | Raymond James | Mkt Perform → Outperform |
Alle ansehen
Baxter International Inc Aktie (BAX) Neueste Nachrichten
Can Execution Lift Baxter International (NYSE:BAX) From Here? - Kalkine Media
Baxter International stock: Company releases Connected Hospital Report on September 30, 2026 - AD HOC NEWS
Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch
What Investors Might Be Missing On Baxter International (BAX) - Yahoo Finance
Baxter Releases Inaugural Connected Hospital Report - Business Wire
Baxter International stock faces a Q3 EPS estimate cut - AD HOC NEWS
Why Investors Need to Take Advantage of These 2 Medical Stocks Now - Zacks Investment Research
Baxter International stock trades above analyst target - AD HOC NEWS
Baxter International (BAX) Q1 2026 Earnings Call Transcript - Fortune
Baxter International (BAX) Q2 2026 Earnings Call Transcript - Fortune
Baxter International stock heads into the open after a 1.9 percent S&P 500 drop - AD HOC NEWS
Here's Why You Should Retain Baxter Stock in Your Portfolio for Now - Eastern Progress
Baxter International stock heads into the open after a 1.2 percent drop - AD HOC NEWS
Baxter International stock holds at USD 22.93 as storm damage weighs - AD HOC NEWS
A Look at Baxter International Inc (BAX) After 3.3% Gain -- GF V - GuruFocus
Baxter International Inc (BAX) Stock Price Today: $23.74 - Pluang
How Baxter International's WNC plant rebuilt post-Helene | Video - The Asheville Citizen Times
Baxter International, McDowell County - Yahoo
Baxter plant's Helene recovery has a human face - The Asheville Citizen Times
Baxter International stock holds near its yearly high - AD HOC NEWS
Baxter International stock gains 0.57 percent ahead of the open - AD HOC NEWS
Baxter International stock gains on cautious analyst tone - AD HOC NEWS
Is Baxter Stock Underperforming the Nasdaq? - Barchart.com
Top 3 Health Care Stocks That May Rocket Higher In September - Benzinga
Baxter International Inc. (BAX) Stock Analysis: Assessing a 26% Potential Upside Amid Healthcare Sector Challenges - DirectorsTalk Interviews
Baxter International stock reacts to guidance after second-quarter 2026 results - AD HOC NEWS
Baxter International stock slips as Q2 beat and raise still matters - AD HOC NEWS
Baxter International stock steadies near recent lows as analysts stick with Hold ratings - AD HOC NEWS
Baxter International stock heads into the open after a 0.8% dip - AD HOC NEWS
Baxter International stock heads into the open after a 0.6% dip - AD HOC NEWS
Baxter International stock rises on 24.5 percent YTD gain - AD HOC NEWS
Baxter International stock heads into the open after a 24.5 percent year-to-date gain - AD HOC NEWS
Baxter International Inc. (BAX) Stock Analysis: Exploring The 20.7% Upside Potential - DirectorsTalk Interviews
Baxter International Inc Share PriceBAX, RNS News, Articles, Quotes, & Charts (NYSE:BAX) - Proactive financial news
Securities Lawsuit Alert: Baxter International, Inc. (BAX) – Contact Levi & Korsinsky Before December 15, 2025 - ACCESS Newswire
Baxter International Inc. stock underperforms Friday when compared to competitors - MarketWatch
Baxter: This Turnaround Stock Is Up and Still 38% Undervalued - morningstar.com
Baxter International stock heads into the open after a modest gain - ad-hoc-news.de
Baxter International Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Transcript : Baxter International Inc. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-09-2026 12 - marketscreener.com
Baxter at Wells Fargo conference: growth improves as turnaround continues By Investing.com - Investing.com UK
A Look at Baxter International Inc (BAX) After 3.8% Decline -- G - GuruFocus
Baxter International stock trades sideways as technical signals flag limited near-term upside - ad-hoc-news.de
Baxter International Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Baxter International stock holds steady as investors await next earnings signal - ad-hoc-news.de
BAX Raises 2026 Outlook as Strong Q2 Growth Offsets Margin Pressure - Yahoo Finance
Human Albumin Market Report Analyzes Growth Factors, Challenges, and Market Dynamics - openPR.com
Don't Ignore The Insider Selling In Abeona Therapeutics - simplywall.st
Baxter International Inc. (BAX) Stock Analysis: Exploring Potential Upside and Analyst Ratings - DirectorsTalk Interviews
Nagaraj Bhat Appointed Vice President/GM, Global Capability Center (GCC) Site Leader at DePuy Synthes - hrtoday.in
Baxter International stock holds steady as investors focus on recent restructuring and earnings prof - ad-hoc-news.de
Finanzdaten der Baxter International Inc-Aktie (BAX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.87%
2.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):